Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,881 | -226,539 | -247,116 | -184,062 | -182,814 |
| Depreciation Amortization | -10,227 | -8,608 | -340 | 775 | 869 |
| Accounts receivable | -22,698 | -6,095 | -21,470 | -20,817 | 13,903 |
| Other Working Capital | -87,282 | -32,401 | -58,945 | 8,124 | 26,875 |
| Other Operating Activity | 157,068 | 178,502 | 166,021 | 53,823 | 6,059 |
| Operating Cash Flow | $-52,020 | $-95,141 | $-161,850 | $-142,157 | $-135,108 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 53,717 | -129,330 | -126,887 | 18,189 | -6,342 |
| PPE Investments | -1,124 | -2,168 | -1,351 | -2,385 | -514 |
| Investing Cash Flow | $52,593 | $-131,498 | $-128,238 | $15,804 | $-6,856 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 300,000 | 73,072 | N/A | 119,867 |
| Debt Repayment | N/A | -261,713 | N/A | 0 | -52,420 |
| Common Stock Issued | 3,478 | 8,682 | 14,955 | 65,794 | 95,725 |
| Other Financing Activity | -9,239 | -14,484 | 0 | 293,874 | 137,417 |
| Financing Cash Flow | $-5,761 | $32,485 | $88,027 | $359,668 | $300,589 |
| Exchange Rate Effect | -936 | 362 | 566 | 71 | N/A |
| Beginning Cash Position | 112,447 | 306,239 | 507,734 | 274,348 | 115,723 |
| End Cash Position | 106,323 | 112,447 | 306,239 | 507,734 | 274,348 |
| Net Cash Flow | $-6,124 | $-193,792 | $-201,495 | $233,386 | $158,625 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,020 | -95,141 | -161,850 | -142,157 | -135,108 |
| Capital Expenditure | -1,124 | -2,168 | -1,351 | -2,385 | -514 |
| Free Cash Flow | -53,144 | -97,309 | -163,201 | -144,542 | -135,622 |